Supplements-10-02-2004

Applied Clinical Trials Supplements

The Future of Clinical Diagnostics

October 02, 2004

Feature Article

0

0

Pharmaceutical industry trends will directly impact the clinical diagnostic world, resulting in a more integrated therapeutic strategy.

The Thorough Phase I ECG

October 02, 2004

Feature Article

0

0

The rapid emergence and global acceptance of new regulatory guidance has thrust cardiac safety to the forefront of new drug development during recent years. This is because the cardiac safety effects of new drugs is the most common cause of drug withdrawal from the market, or delays and a lack of regulatory approval for marketing. The resulting ECG Global Regulatory Imperative creates issues and offers opportunities for new drug developers striving for Best Practices in this important area.